1.
Rev Gastroenterol Mex
; 44(2): 63-6, 1979.
Article
in Spanish
| MEDLINE
| ID: mdl-379956
ABSTRACT
Two cirrhotic patients with hepatorenal syndrome were treated with Dopamine hydrochloride and Bromocriptine, a Dopamine agonist. Dopamine hydrochloride was given at a dosis of 0.30 to 0.90 mg/min. and Bromocriptine 15 mg/day. Although a transient raise of urinary output was observed in one patient, both patients died six to ten days later with an urinary output of less than 100 ml/day. Dopamine and Bromocriptine combined are of poor therapeutic value in hepatorenal syndrome.
Subject(s)
Bromocriptine/therapeutic use , Dopamine/therapeutic use , Kidney Diseases/drug therapy , Liver Cirrhosis/drug therapy , Adult , Clinical Trials as Topic , Drug Evaluation , Female , Hepatitis/complications , Humans , Injections, Intravenous , Liver Cirrhosis/etiology , Male , Middle Aged
2.
Rev Invest Clin
; 30(4): 379-83, 1978.
Article
in Spanish
| MEDLINE
| ID: mdl-715311